Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
4.460
+0.030 (0.68%)
Mar 25, 2026, 9:41 AM EDT - Market open
Evolus Market Cap
Evolus has a market cap or net worth of $290.17 million as of March 25, 2026. Its market cap has decreased by -64.01% in one year.
Market Cap
290.17M
Enterprise Value
389.39M
1-Year Change
-64.01%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $290.17M, an increase of 6.95%. That is a compound annual growth rate of 0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 288.20M | -33.15% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 495.70M |
| Kamada | 490.33M |
| Aquestive Therapeutics | 485.74M |
| Emergent BioSolutions | 426.70M |
| Akebia Therapeutics | 380.39M |
| Canopy Growth | 363.66M |
| SIGA Technologies | 353.92M |
| Organogenesis Holdings | 307.45M |